
Envista Holdings Corporation (NYSE:NVST - Free Report) - Research analysts at Leerink Partnrs increased their Q3 2025 earnings per share estimates for shares of Envista in a research report issued to clients and investors on Thursday, July 31st. Leerink Partnrs analyst M. Cherny now expects that the company will post earnings of $0.28 per share for the quarter, up from their previous forecast of $0.25. The consensus estimate for Envista's current full-year earnings is $1.00 per share. Leerink Partnrs also issued estimates for Envista's Q4 2025 earnings at $0.33 EPS, FY2025 earnings at $1.10 EPS, FY2026 earnings at $1.14 EPS, FY2027 earnings at $1.35 EPS and FY2028 earnings at $1.49 EPS.
Envista (NYSE:NVST - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The company reported $0.26 EPS for the quarter, topping analysts' consensus estimates of $0.24 by $0.02. Envista had a return on equity of 4.84% and a net margin of 2.11%. The company had revenue of $682.10 million for the quarter, compared to analyst estimates of $638.21 million. During the same quarter last year, the firm posted $0.11 earnings per share. Envista's revenue was up 7.7% compared to the same quarter last year.
A number of other research analysts also recently commented on NVST. Stifel Nicolaus boosted their price target on Envista from $24.00 to $25.00 and gave the company a "buy" rating in a research note on Friday, August 1st. Bank of America reduced their target price on shares of Envista from $26.00 to $23.00 and set a "buy" rating on the stock in a report on Tuesday, April 29th. Wells Fargo & Company raised their target price on Envista from $17.00 to $19.00 and gave the stock an "equal weight" rating in a research report on Friday, August 1st. UBS Group lifted their price objective on Envista from $18.00 to $22.00 and gave the stock a "neutral" rating in a research note on Tuesday, July 29th. Finally, Piper Sandler upped their price objective on shares of Envista from $17.00 to $19.00 and gave the company a "neutral" rating in a research note on Friday, August 1st. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating, four have given a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $20.92.
Check Out Our Latest Stock Analysis on Envista
Envista Stock Performance
Shares of NVST traded up $0.25 during trading hours on Monday, hitting $19.96. The company had a trading volume of 734,824 shares, compared to its average volume of 2,622,944. The business has a fifty day moving average of $19.55 and a 200-day moving average of $18.63. The firm has a market cap of $3.32 billion, a price-to-earnings ratio of 62.44, a PEG ratio of 1.07 and a beta of 1.00. Envista has a 12 month low of $14.22 and a 12 month high of $23.00. The company has a quick ratio of 2.08, a current ratio of 2.44 and a debt-to-equity ratio of 0.46.
Institutional Trading of Envista
Institutional investors and hedge funds have recently bought and sold shares of the business. Alliancebernstein L.P. raised its stake in shares of Envista by 1,985.1% during the first quarter. Alliancebernstein L.P. now owns 4,550,789 shares of the company's stock worth $78,547,000 after purchasing an additional 4,332,541 shares during the last quarter. Brickwood Asset Management LLP purchased a new position in Envista during the 4th quarter worth $40,037,000. Norges Bank purchased a new stake in shares of Envista in the fourth quarter valued at about $38,052,000. Dimensional Fund Advisors LP boosted its holdings in shares of Envista by 24.0% in the first quarter. Dimensional Fund Advisors LP now owns 8,387,297 shares of the company's stock valued at $144,760,000 after acquiring an additional 1,625,206 shares in the last quarter. Finally, Pzena Investment Management LLC increased its stake in shares of Envista by 160.7% during the first quarter. Pzena Investment Management LLC now owns 2,294,257 shares of the company's stock worth $39,599,000 after acquiring an additional 1,414,080 shares during the period.
Envista Company Profile
(
Get Free Report)
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Recommended Stories

Before you consider Envista, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Envista wasn't on the list.
While Envista currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.